Johnson & Johnson JNJ | NYSE
Company Overview:
10 Year JNJ Performance Metrics:
JNJ Dividend Charts
Build Custom Charts
JNJ Financials: Earnings, Revenue, Cash Flow, Ebitda, Cash/Debt, Shares Float, etc:
Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:
Ratios, Profit Margins & Return on Capital:
JNJ Dividends Info:
Projected Future Returns & Dividends for JNJ
Based on past 10-year performance, here are JNJ growth metrics:
Share price CAGR of +8.9%
Dividend CAGR of +5.29%
Using JNJ CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:
| JNJ (DRIP) | JNJ - No DRIP | |
|---|---|---|
| Current Price | $282.11 | $282.11 |
| Start Shares | 35.45 | 35.45 |
| Start Value | $10,000 | $10,000 |
| After 10 years: | ||
| Final Share Count | 41.75 | 35.45 |
| Dividends Payment | $2.24 | $2.24 |
| Annual Dividends | $375 | $318 |
| Yield on cost | 3.75% | 3.18% |
| Share Price | $661.51 | $661.51 |
| Total Dividends | $2,657 | $2,423 |
| Final Value | $27,620 | $25,871 |
NOTE: Above numbers are our estimate based on JNJ's Dividend and Price CAGR over past 10 years.
These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.
We cannot guarantee that your actual returns will meet these estimates.
Pro adds JNJ's Dividend Safety Rating, its DCF fair value and the Trend Signal to this page and opens the 28 blurred charts above.
Show JNJ's rating and fair valueCompany Info
Johnson & Johnson (JNJ) had its IPO on 1962-01-02, and is traded on NYSE stock exchange.
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.
JNJ website: https://www.jnj.com
DCF Model — JNJ
FCF is negative or missing for this company (common for banks) — the model discounts EPS instead.
EPS is negative or missing for this company — Simple mode uses free cash flow per share instead.
| Year | FCF | Implied price |
|---|
